WebJun 9, 2024 · Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform that is designed to … WebApr 20, 2024 · Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform...
Cytocom, Inc. and La Jolla Institute for Immunology Announce Five …
WebImmune Therapeutics, Inc. (“the Company”, “Immune”) was initially incorporated in Florida on December 2, 1993, as Resort Clubs International, Inc. (“Resort Clubs”). It was formed to manage and market golf course properties in resort markets throughout the United States. ... In December 2013, the Company formed a subsidiary, Cytocom ... WebImmune Therapeutics and Cytocom are planning to work with federal agencies to seek fast-track approval using Lodonal™ as a way to prevent or treat COVID-19 in high-risk groups who are infected with 2024-nCoV at clinical research centers across the country. IMUN is currently designing studies using Lodonal™ and IRT-101 as a monotherapy or in ... gustavo recliner parts screws
Immune Therapeutics, Inc. (Form: 8-K, Received: 11/09/2024 …
WebSep 28, 2024 · Cytocom is developing therapies designed to elicit directly within patients a robust and durable response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. WebStatera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, … WebCytomX is a different kind of clinical-stage biopharmaceutical company – intent on revolutionizing the way we treat cancer. Our distinctive Probody ® therapeutics are … gustavortech office